Chunping Xu, Ph.D

Senior Director of Chemistry R&D at TriLink BioTechnologies

Speaker

Chunping Xu, PhD, is the Senior Director of R&D at TriLink Biotechnologies, where she oversees the novel CleanCap® analogue development and also the development of mRNA tail modification technology(ModTail) for higher protein expression and longer duration of protein expression. In addition, she and her team have been investigating how to improve mRNA performance through a holistic approach: optimizing mRNA from cap to tail. Leveraging expertise in nucleotide chemistry, Dr. Xu and her team have created a library of 200 plus novel cap analogs and have found and launched CleanCap M6 as one of the best co-transcriptional capping reagents that can significantly improve mRNA performance. Also Dr. Xu and her team have explored mRNA tail modification extensively and have launched the first-to-market ModTail technology to meet the needs of more stable mRNA with longer duration in cells. Before joining TriLink, she had extensive experience in small molecule drug development and conjugation.